Page last updated: 2024-08-23

sq-11725 and Basal Ganglia Diseases

sq-11725 has been researched along with Basal Ganglia Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arheart, KL; Ayubi, MA; Brown, CS; Chu, CC; Cold, JA; Johnson, RP; Knott, DH; Marken, PA; Nasdahl, CS; Wells, BG	1

Trials

1 trial(s) available for sq-11725 and Basal Ganglia Diseases

Article	Year
A placebo-controlled trial of nadolol in the treatment of neuroleptic-induced akathisia. The Journal of clinical psychiatry, 1991, Volume: 52, Issue:6 Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Basal Ganglia Diseases; Double-Blind Method; Drug Administration Schedule; Female; Hospitalization; Humans; Male; Middle Aged; Nadolol; Placebos; Psychomotor Agitation	1991

Article

Year

A placebo-controlled trial of nadolol in the treatment of neuroleptic-induced akathisia.

The Journal of clinical psychiatry, 1991, Volume: 52, Issue:6

Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Basal Ganglia Diseases; Double-Blind Method; Drug Administration Schedule; Female; Hospitalization; Humans; Male; Middle Aged; Nadolol; Placebos; Psychomotor Agitation

1991